Sunwin Stevia International, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2020
September 11, 2020 at 03:59 pm EDT
Share
Sunwin Stevia International, Inc. announced earnings results for the first quarter ended July 31, 2020. For the first quarter, the company announced total revenue was USD 7.039 million compared to USD 6.890 million a year ago. Operating loss was USD 978,351 compared to operating Income of USD 37,862 a year ago. Net loss was USD 662,599 compared to USD 383,235 a year ago.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.